Core Viewpoint - Pomerantz LLP is investigating claims on behalf of investors of Above Foods Ingredients Inc. regarding potential securities fraud or unlawful business practices by the company and its officers or directors [1]. Group 1: Company Developments - On December 2, 2025, Above Food disclosed that its auditor had resigned in July at the company's request [3]. - Following the auditor's resignation announcement, Above Food's stock price fell by $0.23 per share, or 7.67%, closing at $1.69 per share on December 19, 2025 [3]. Group 2: Legal Context - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of fighting for victims of securities fraud and corporate misconduct [4].

Core Viewpoint - Pomerantz LLP is investigating claims on behalf of investors of Nektar Therapeutics regarding potential securities fraud or unlawful business practices by the company and its officers or directors [1]. Group 1: Company Performance - On December 16, 2025, Nektar announced topline results from the Phase 2b REZOLVE-AA trial of its investigational drug rezpegaldesleukin, which failed to reach statistical significance due to the inclusion of four ineligible patients [3]. - Following the announcement of the trial results, Nektar's stock price dropped by $4.14 per share, or 7.77%, closing at $49.16 per share on the same day [4]. Group 2: Legal Investigation - Pomerantz LLP, a firm known for its work in corporate and securities class litigation, is leading the investigation into Nektar's business practices and potential fraud [5].

Core Viewpoint - Pomerantz LLP is investigating claims on behalf of investors of Charming Medical Limited regarding potential securities fraud or unlawful business practices by the company and its officers or directors [1]. Group 1: Investigation and Legal Actions - The U.S. Securities and Exchange Commission (SEC) issued an order to halt trading of Charming Medical securities due to potential manipulation through social media recommendations aimed at artificially inflating the price and trading volume of the company's securities [3]. - Trading in Charming Medical's securities was suspended starting on November 12, 2025, following the SEC's order [3]. Group 2: Pomerantz LLP Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of over 85 years in fighting for the rights of victims of securities fraud and corporate misconduct [4]. - The firm has successfully recovered numerous multimillion-dollar damages awards on behalf of class members [4].

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud or unlawful business practices involving Duluth Holdings Inc. and its officers or directors [1] Financial Performance - On December 16, 2025, Duluth announced a reduction in its net sales guidance to a range of $555 million to $565 million, down from the previous guidance of $570 million to $595 million [3] - Following this announcement, Duluth's stock price dropped by $0.92 per share, representing a decline of 29.39%, closing at $2.21 per share on the same day [3]

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming February 17, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired SLM Corporation a/k/a Sallie Mae ("SLM†or the "Company†) (NASDAQ: SLM) securities between July 25, 2025 and August 14, 2025, inclusive (the "Class Period†). What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defen ...

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the merger between OceanFirst Financial Corp. and Flushing Financial Corp. for OceanFirst shareholders, who are expected to own approximately 58% of the combined entity upon completion of the transaction [1]. Group 1 - The investigation focuses on whether OceanFirst and its board violated federal securities laws or breached fiduciary duties by not obtaining the best possible consideration for shareholders and failing to disclose all material information necessary for assessing the merger [3]. - Halper Sadeh LLC may seek increased consideration for OceanFirst shareholders, additional disclosures, and other relief related to the proposed transaction [4].

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the merger between EKSO Bionics Holdings, Inc. and Applied Digital Cloud for EKSO shareholders [1][2]. Group 1: Investigation Details - The investigation focuses on whether EKSO and its board violated federal securities laws and/or breached fiduciary duties by not obtaining the best possible consideration for shareholders [2]. - The investigation also questions if EKSO disclosed all material information necessary for shareholders to adequately assess and value the merger [2]. Group 2: Potential Actions - On behalf of EKSO shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures, and other relief related to the proposed transaction [3]. - The legal action would be handled on a contingent fee basis, meaning shareholders would not be responsible for out-of-pocket legal fees or expenses [3]. Group 3: Firm Background - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, having recovered millions for defrauded investors [4].

SAN FRANCISCO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is alerting investors in Primo Brands Corporation (NYSE: PRMB) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 12, 2026. The firm urges investors who suffered substantial losses to contact our firm now. The lawsuit seeks to recover investor losses sustained after the disclosure of an allegedly concealed severe, operational crisis ...

Core Viewpoint - Hagens Berman is reminding investors in Stride, Inc. (NYSE: LRN) about the deadline of January 12, 2026, to apply for lead plaintiff status in a securities class action lawsuit related to significant losses incurred by investors due to alleged fraudulent activities [1][9]. Group 1: Allegations of Fraud - The lawsuit claims that Stride engaged in two fraudulent schemes: inflating enrollment figures through "Ghost Students" and a significant technology platform failure, which collectively caused a 54% stock crash in a single day, resulting in billions in market capitalization loss [2][4]. - Stride and its executives are accused of misleading investors regarding core business metrics and operational stability, particularly in light of a platform upgrade failure that CEO James Rhyu admitted led to a "poor customer experience" [3][4]. Group 2: Specific Allegations - **Enrollment Fraud**: Stride allegedly retained "Ghost Students" to artificially inflate enrollment metrics, which contributed to an 11% stock drop upon partial disclosure of these practices [6]. - **Technology Catastrophe**: The company reportedly failed to disclose severe issues with a critical platform upgrade that blocked access for approximately 10,000 to 15,000 students, leading to a forecasted sales growth reduction to 5% from a historical 19%, triggering the 54% stock crash [7][8]. Group 3: Legal Proceedings and Investor Impact - The complaint seeks to recover losses for investors who purchased LRN securities during the Class Period from October 22, 2024, to October 28, 2025, holding Stride and its executives accountable for alleged misrepresentations [9]. - Hagens Berman is actively advising affected investors and emphasizes the importance of contacting them to discuss potential recovery options [10][11].

Core Viewpoint - A class action securities lawsuit has been filed against SLM Corporation, alleging securities fraud that affected investors between July 25, 2025, and August 14, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that SLM Corporation made false statements regarding its financial health, specifically that the company was experiencing a significant increase in early-stage delinquencies [2]. - It is alleged that SLM overstated the effectiveness of its loss mitigation and loan modification programs, misleading investors about the stability of its private education loan delinquency rates [2]. - The public statements made by the defendants are said to have created a materially false and misleading impression about SLM's business operations and future prospects [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified time frame have until February 17, 2026, to request to be appointed as lead plaintiff in the lawsuit [3]. - Participation in the lawsuit does not require investors to incur any out-of-pocket costs or fees, as class members may be entitled to compensation without financial obligation [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]. - The firm has extensive expertise in complex securities litigation and employs a team of over 70 professionals dedicated to serving clients [4].